Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.

Also called NCT04950790

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 480 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04950790
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04950790. Randomized; double masking; primary purpose treatment. Start 2018-04-01 (actual); primary completion 2021-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
Shuxinin injection
Intervention (Drug)
Basic treatment
Intervention (Drug)
Placebo
Lead sponsor
Peking University Third Hospital (class: other)
Collaborator
Handan Central Hospital (class: other)

Record details

Record id
cardio:ct-nct04950790
Content hash
9e0540fda73cac2f120453ae0b6c74973c6a87fb991ec0e7472785e5ff4726e1